Urinary Tract Infections And Urinary Incontinence

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

1 comments

Comments 1 - 1 of 1 previous next Post a comment

Post a comment
Embed Video
Edit your comment Cancel

Favorites, Groups & Events

Urinary Tract Infections And Urinary Incontinence - Presentation Transcript

  1. Urinary Tract Infections and Urinary Incontinence By Ana Corona, FNP-Student University of Phoenix January 2003 More presentations at: www.nurseana.com
  2. Prevalence of UTIs
    • Urinary Tract Infection (UTI) is the most common bacterial infection affecting humans
    • UTI is a serious health problem affecting millions of people each year
    • Over 8 million Americans seek medical attention for urinary tract infections annually.
    • Women are especially susceptible: one in five women will have at least one urinary tract infection during her life .
  3. Pathophysiology
    • The urinary system consists of the kidneys, ureters, bladder, and urethra.
    • The kidneys remove liquid waste from the blood in the form of urine
    • Keep a stable balance of salts & substances in the blood, and produce a hormone that aids the formation of RBCs.
  4. Pathophysiology: continued
    • The ureters carry urine from the kidneys to the bladder located in the lower abdomen.
    • Urine is stored in the bladder and emptied through the urethra.
    • The ureters and bladder normally prevent urine from backing up toward the kidneys, and the flow of urine from the bladder helps wash bacteria out of the body
    • Normal urine is sterile.
    • It contains fluids, salts, and waste products.
    • It is free of bacteria, viruses, and fungi.
  5. Pathophysiology: Routes of Infection
    • Three well recognized routes of infection:
    • Ascending Transurethral Infection : fecal microorganisms colonizing the periurethral area and enter the bladder via the urethra
    • Hematogenous : spread as in staphylococcal bacteremia or renal cortex resulting in abscess formation
    • Direct Extension : enterovesical fistula
  6. Pathophysiology: Ascending Transurethral Infection
    • Is most common route
    • Short female urethra allows bacteria quick access to the bladder.
    • Sexual intercourse forces bacteria into bladder
    • Presence of foreskin, fecal incontinence, and poor toilet habits promote colonization by the fecal bacteria and contribute to the higher prevalence of infection seen in uncircumcised infants, young sexually active men and elderly men with poor anal sphincter control
  7. Pathophysiology: Hematogenous Spread
    • Hematogenous spread of bacteria, fungi, and mycobacteria from distant focus of infection may invade the kidney, bladder or prostate
  8. Pathophysiology: Direct Extension
    • Direct extension of bacteria from the gut into the bladder may occur via a colovesical fistula secondary to diverticulitis or colon cancer, Crohn’s disease
  9. Classification of Urinary Tract Infections
    • Lower UTI : cystitis, urethritis, prostatitis
    • Upper UTI : acute or chronic pyelonephritis, renal or perirenal abscess
    • Uncomplicated and Complicated lower or upper UTI
  10. Classification of Urinary Tract Infections
    • Complicated Lower or Upper UTI:
      • Risk of renal damage, urosepsis, abscess formation
    • Due to
    • Presence of functional or anatomic abnormalities, obstruction, calculi/catheter/stent, pregnancy, hospitalization, immunosuppression, diabetes mellitus, sickle cell disease, analgesic/NSAID abuse
  11. Classification of Urinary Tract Infections
    • Acute urethral syndrome : dysuria/frequency with less than 10/ 5 colonies/ml of urine
    • Asymptomatic bacteriuria : asymptomatic with more than 10/ 5 colonies of the same bacteria per ml of clean-catch mid-stream urine
  12. Presenting Signs & Symptoms Uncomplicated lower UTI
    • Acute Bacterial Cystitis:
    • Dysuria
    • Frequency
    • Urgency
    • Nocturia
    • Voiding of small urine volumes
    • Incontinence
    • Suprapubic or pelvic pain
  13. Associated Signs & Symptoms
    • Hematuria
    • Foul smelling cloudy urine
    • Men experience a fullness in the rectum
    • Fever
    • Flank tenderness
  14. Acute pyelonephritis
    • Signs & Symptoms :
      • Flank or low back pain, chills, fever, sweats, nausea, vomiting, headache and malaise
    • Associated Signs & Symptoms :
      • May have symptoms of cystitis
      • Hematuria, dysuria, polyuria
  15. Signs & Symptoms in the Elderly
    • Less obvious signs:
    • Loss of appetite or a change in eating habits.
    • The sudden onset of confusion
    • Urinary incontinence
  16. Complicated UTI: S/S
    • Clinical manifestations can range from asymptomatic bacteriuria to a severe gram-negative sepsis with shock
    • Can also present with signs and symptoms of acute cystitis or acute pyelonephritis
    • Hospitalized patients who suddenly develop signs and symptoms of septic shock or urosepsis should be considered even in the absence of urinary symptoms, particularly after a recent instrumentation of catherization.
  17. Physical Findings
    • Acute Cystitis:
      • Suprapubic tenderness and distension
    • Acute Pyelonephritis:
      • Fever 104 F
      • Abdominal distension, hypotonic bowel sounds, severe tenderness in lumbar region
  18. Physical Examination
    • PE in men should include:
    • Inspection and palpation of the genitals for evidence of urethral discharge, meatal erythema, inflammation of the glans penis, penile lesions, enlarged or tender epididymis or testicle, and inguinal lymphadenopathy.
    • A rectal examination with palpation of the prostate gland should be a standard part of the PE in all men with UTI symptoms
  19. Diagnostic studies:
    • Urinalysis "clean catch“ (midstream)
    • Urine Culture & Sensitivity
    • When an infection does not clear up with treatment and is traced to the same strain of bacteria further tests may be ordered:
    • Computed Tomography (CT)
    • Ultrasound
    • Intravenous Pyelogram (IVP)
    • Cystoscope
  20. Diagnostics
    • Urinalysis test: urine is examined for white and red blood cells and bacteria.
    • Urine Culture & Sensitivity: bacteria are grown in a culture and tested against different antibiotics to see which drug best destroys the bacteria.
    • Some microbes, like Chlamydia and Mycoplasma, can be detected only with special bacterial cultures.
    • One of these infections are suspected when there are symptoms of a UTI and pus in the urine, but a standard culture fails to grow any bacteria.
  21. Differential Diagnosis
    • Acute Bacterial Cystitis should be differentiated from vulvovaginitis caused by yeast, trichomoniasis species or bacterial infections
    • STDs involving the urethra and cervix such as those caused by C. trachomatis, N. Gonorrhoeae and herpes simplex virus.
    • Between 10% to 30% of women with STDs or other forms of vaginitis have frequency and dysuria
  22. Clinical Decision Making: Differential Diagnosis
    • Vulvovaginitis : external dysuria, soreness of the vulva, malodorous vaginal discharge, pruritus and dyspareunia
    • Pyuria and hematuria is rare
    • Urine culture reveals less than 10/ 2 colonies/ml
    • Urethritis: caused by sexually transmitted pathogens- gradual onset of dysuria without other urinary symptoms, vaginal discharge or bleeding or lower abdominal pain.
    • Pyuria with urine culture showing less than 10/ 2 colonies/ml
    • No hematuria
  23. Clinical Decision Making based on Laboratory Findings
    • Urine Dip Stick:
      • bacterial counts >10/ 5 Enterobacteriaceae/ml of urine with concomitant pyuria can be detected by this method
    • Microscopic examination of centrifuged urine can detect the presence of significant pyuria (>4 WBCs per high power field), hematuria (>4 RBCs per high-power field) or both.
    • This provides further support for the diagnosis of UTI
  24. Clinical Decision Making based on Laboratory Findings
    • Leukocyte casts: strongly support the diagnosis of pyelonephritis
    • Urine culture: identifies pathogenic microorganism
    • 1 st a.m. Urine: presence of >1 bacterium per high-power field on a gram-stained film of uncentrifuged urine correlates with >10/ 5 bacterial colonies/ml in 90% of pts
  25. Clinical Decision Making: Differential Diagnosis
    • Presence of pyuria does not differentiate upper from lower UTIs
    • Pyuria in the absence of bacteriuria should raise the possibility of renal tuberculosis or allergic interstitial nephritis
    • Postmenopausal Women: atrophic changes in mucosa of the vulvovagina and urethra caused by hormone deficiency may result in persistent or recurrent frequency and dysuria
    • Renal and genitourinary neoplasms need to be ruled out
  26. Differential Diagnosis
    • Acute Pyelonephritis
      • Young female patient should be differentiated from:
      • Pelvic inflammatory disease
      • Appendicitis
      • Atopic pregnancy
      • Ruptured ovarian cyst
  27. Etiology: Risk Factors
    • Any abnormality of the urinary tract that obstructs the flow of urine such as a kidney stone, sets the stage for an infection.
    • An enlarged prostate gland can slow the flow of urine - raising the risk of infection
    • A common source of infection is catheters, or tubes, placed in the bladder.
    • The elderly or those with nervous system disorders who lose bladder control, may need a catheter for life
  28. Etiology: Risk Factors
    • People with diabetes have a higher risk of a UTI because of changes in the immune system.
    • Immunosuppressed patients are at risk of a urinary infection.
    • For many women, sexual intercourse seems to trigger an infection
    • Women who use a diaphragm are more likely to develop a UTI than women who use other forms of birth control.
    • Women whose partners use a condom with spermicidal foam also tend to have growth of E. coli bacteria in the vagina
  29. Recurrent UTI infections
    • Nearly 20% of women who have a UTI will have another
    • 30% of those will have yet another.
    • Of the last group, 80 percent will have recurrences.
    • Usually, the latest infection stems from a strain or type of bacteria that is different from the infection before it, indicating a separate infection.
    • Even when several UTIs in a row are due to E. coli, slight differences in the bacteria indicate distinct infections.
  30. Uncomplicated UTIs TMP-SMZ or 1 st generation cephalosporin Staphylococcus saprophyticus Amoxicillin Enterococcus faecalis TMP-SMZ or 1 st generation cephalosporin Klebsiella pneumoniae Amoxicillin or TMP-SMZ Proteus mirabilis TMP-SMZ or 1 st generation cephalosporin Escherichia coli Antibacterial of Choice: Organisms Commonly Found:
  31. Complicated UTIs Antipseudomonal penicillin + aminoglycoside; ceftazidime; fluoroquinolone Pseudomonas Penicillinase-resistant penicillin or vancomycin Staphylococcus Imipenem; TMP-SMZ Acinetobacter 3 rd generation cephalosporin; TMP-SMZ Indole-+ Proteus & Serratia Fluoroquinolone; TMP-SMZ; Imipenem Enterobacter Ampicillin or vancomycin + aminoglycoside Enterococcus faecalis 1 st , 2 nd , or 3 rd generation cephalosporin E-coli, Proteus & Klebsiella
  32. Clinical Decision Making: Upper vs. Lower UTI
    • Clinical signs and symptoms may not always be accurate for distinguishing between Upper and Lower UTIs
    • Distinction between them is best assessed by the response to treatment
  33. Clinical Decision Making :
    • UTIs are treated with antibacterial drugs.
    • The choice of drug and length of treatment depend on the patient's history and the urine tests that identify the offending bacteria.
    • The sensitivity test is especially useful in helping to select the most effective drug.
  34. Acute Uncomplicated Cystitis: Single Dose Treatment Single Dose
    • TMP-SMZ 320/1600 mg, 2 double strength tabs
    • Amoxicillin 3gm
    • Cephaloridine 2gm
    • Gentamicin 5 mg/kg
    • Doxycycline 300 mg
    Young woman, first episode
  35. Acute Uncomplicated Cystitis: Short Course Treatment Short course 3 to 5 days
    • Trimethoprim 100-200mg q 12 hrs
    • TMP-SMZ 160/800 mg q 12 hrs
    • Nitrofurantoin 100 mg q 8 or 6 hrs
    • Amoxicillin 250 mg q 8 hrs
    • Ciprofloxacin 250-500 mg q 12 hrs
    • Norfloxacin 400 mg q 12 hrs
    Young woman, first episode
  36. Acute Uncomplicated Cystitis: 7 to 10 days
    • Trimethoprim 100-200mg q 12 hrs
    • TMP-SMZ 160/800 mg q 12 hrs
    • Nitrofurantoin 100 mg q 8 or 6 hrs
    • Amoxicillin 250 mg q 8 hrs
    • Ciprofloxacin 250-500 mg q 12 hrs
    • Norfloxacin 400 mg q 12 hrs
    • Diabetes
    • Mellitus
    • Symptoms
    • >7 days
    • Age >65 yrs
    • Diaphragm
  37. Acute Uncomplicated Cystitis 7 to 10 days
    • Trimethoprim 100-200mg q 12 hrs
    • TMP-SMZ 160/800 mg q 12 hrs
    • Ciprofloxacin 250-500 mg q 12 hrs
    • Norfloxacin 400 mg q 12 hrs
    Young healthy man
  38. Recurrent Cystitis Single dose or 3-5 days 3-5 days, then 1 yr of prophylaxis TX as 1 st episode in young woman TMP+SMZ, amoxicillin, Nitrofurantoin, ciprofloxacin or Norfloxacin, followed by low-dose antibiotic prophylaxis Reinfection: < 2 episodes/yr > 3 episodes/yr 14 days
    • TX based on sensitivity results
    • R/O renal stones,
    • Scars, cysts,
    • Chronic Bacterial
    • Prostatitis
    Relapses
  39. Recurrent Cystitis Topical estradiol cream+low-dose antibiotic prophylaxis Postmenopause Postcoital prophylaxis TMP+SMZ, Nitrofurantoin cephalexin; voiding after intercourse Temporally related to coitus
  40. Asymptomatic Bacteriuria 3 – 5 days Amoxicillin/Ampicillin, Nitrofurantoin oral cephalosporin Pregnancy 10 – 14 days No TX unless symptomatic, neutropenic, renal transplant, urea splitting bacteria, obstruction, diabetes mellitus, sickle cell disease/trait, NSAID/analgesic abuse With/without catheter
  41. Acute Uncomplicated Pyelonephritis 14 days Parenteral: ceftriaxone, gentamicin+ampicillin, aztreonam, or TMP-SMZ until afebrile, then oral regimen Pregnancy 14 days; if relapse, 6 weeks Oral: TMP+SMZ, amoxicillin, ciprofloxacin, Norfloxacin Not very sick Very sick or septic 14 days; if relapse, 6 weeks Parenteral: TMP-SMZ, ciprofloxacin, ceftriaxone, or gentamicin+ampicillin until afebrile, then oral regimen
  42. Symptomatic Complicated Upper UTI 2 – 3 week; if relapse, 6 weeks Oral: ciprofloxacin, Norfloxacin, or TMP-SMZ (if sensitive) Not very sick 2 – 3 week; if relapse, 6 weeks Parenteral: gentamicin+ampicillin, ceftriaxone, aztreonam, imipenem-cilastatin, ciprofloxacin, ticarcillin-clavulanate Very sick or septic
  43. Patient Education
    • Teach proper hygiene: Women wipe from front to back to prevent bacteria around the anus from entering the vagina or urethra.
    • Take showers instead of tub baths
    • Encourage patient to increase fluid intake and avoid of bladder irritants such as caffeine, smoking and alcohol.
    • Recommend cranberry juice that may decrease bladder colonization
    • Encourage patient to urinate when he/she feels the need
  44. Patient Education: Continue
    • Advise voiding before and after sex
    • Cleanse the genital area before and after sexual intercourse.
    • Recommend alternative methods of contraception for women using diaphragms if recurrent infections exist
    • Avoid using feminine hygiene sprays and scented douches, which may irritate the urethra.
    • Discuss the need to complete entire course of medication
  45. Follow-up & Referrals
    • Follow-up:
    • Repeat U/C after completion of medication
    • Advise pt to return if s/s increase in severity or fail to improve after 3 days of therapy.
    • Consultation/Referral if:
    • Renal Calculi are suspected
    • Infection persists after two courses of appropriate treatment
    • If pyelonephritis is suspected
    • If patient has insulin dependent diabetes
    • When patient has existing renal disease
    • History of 3 UTIs in one year
  46. Research
    • Research funded by the National Institutes of Health (NIH) suggests that one factor behind recurrent UTIs may be the ability of bacteria to attach to cells lining the urinary tract.
    • A recent NIH-funded study has also shown that women with recurrent UTIs tend to have certain blood types.
    • Some researchers speculate that women with these blood types are more prone to UTIs because the cells lining the vagina and urethra may allow bacteria to attach more easily.
    • Further research will show whether this association is sound and proves useful in identifying women at high risk for UTIs.
  47. Research
    • Researchers at the University of Washington found that 2-week therapy with TMP/SMZ was as effective as 6 weeks of treatment with the same drug in women with kidney infections that did not involve an obstruction or nervous system disorder.
    • In such cases, kidney infections rarely lead to kidney damage or kidney failure unless they go untreated
  48. Research: Vaccine Development
    • In the future, scientists may develop a vaccine that can prevent UTIs from coming back.
    • Researchers in different studies have found that children and women who tend to get UTIs repeatedly are likely to lack proteins called immunoglobulins, which fight infection.
    • Children and women who do not get UTIs are more likely to have normal levels of immunoglobulins in their genital and urinary tracts
  49. Research: Vaccine Development Continued
    • Early tests indicate that a vaccine helps patients build up their own natural infection-fighting powers.
    • The dead bacteria in the vaccine do not spread like an infection; instead, they prompt the body to produce antibodies that can later fight against live organisms.
    • Researchers are testing injection and oral vaccines to see which works best.
    • Another method being considered for women is to apply the vaccine directly as a suppository in the vagina
  50. Urinary Incontinence (UI)
    • UI is the involuntary loss of urine severe enough to result in social or hygienic consequences
    • It is a major clinical problem and a significant cause of disability and dependence
    • Affects an estimate of 13 million adults in the United States
    • 10% to 20% women age 15 to 64 years
    • 40% women >60 years
  51. Urinary Incontinence:
    • It results in a loss of self-esteem and a decrease in ability to maintain an independent lifestyle
    • UI is one of the major causes of institutionalization of the elderly
    • 1995 – cost of treatment $26 billion for patients over age 65 years
  52. Relevant Pathophysiology: Process of Urination
    • In adults the process of urination involves voluntary and reflexive control of the bladder, urethra, detrusor muscle and urethral sphincter.
    • When bladder volume reaches approx 400-500cc, stretch receptors send nerve impulses to the spinal cord.
    • Nerve impulses leaving the cord then cause the bladder to contract and the sphincters to relax so that urination may take place
    • Urinary Incontinence occurs as a result of a disruption at any point in the process
  53. Risk Factors for Urinary Incontinence include any of the following:
    • Birth defects
    • Childbirth
    • CHF
    • Constipation - Impaction
    • Decreased mobility
    • Diabetes Mellitus
    • Diuretic medication
    • Hormone imbalances in women
    • Infection/inflammation of the urinary tract, vagina, or prostate
    • Injury or trauma
    • Medication Effects
    • Menopause
    • Nerve disorders or injuries
    • Overactive bladder muscles
    • Pelvic radiation Thx
    • Pelvic surgery
    • Polyuria
    • Prostate enlargement
    • Psychological factors
    • Weakness of the bladder, muscles that support the bladder or
    • Sphincter muscles that surround the urethra
  54. S/S: UI is a Symptom
    • UI is a symptom rather than a disease
    • It can be caused by
      • Anatomical
      • Physiological
      • pathological (genitourinary) factors
    • That may Affect the urinary tract as well as external (nongenitourinary) factors
    • Multiple and interacting factors often contribute to UI development especially in frail older patients
  55. S/S of UI including all of the following :
    • Events precipitating incontinence: cough, exercise, straining
    • Dribbling, bladder pain with filling
    • Lower urinary tract infection symptoms:
      • Dysuria, hematuria, hesitancy, nocturia, frequency, poor or interrupted stream, straining, suprapubic or perineal pain
  56. Physical Examination
    • Abdominal examination to assess for:
      • Diastasis recti
      • Fluid collections
      • Masses
      • Organomegaly
      • Peritonitis
    • Genital examination in men for:
      • Skin conditions
      • Abnormalities of:
        • Foreskin
        • Glans penis
        • Perineal skin
  57. Physical Examination: continued
    • Neurologic Examination for:
      • Abnormalities that may suggest:
      • Multiple sclerosis
      • Stroke
      • Spinal cord compression
      • Other neurologic conditions
    • Elderly or frail patients to assess:
      • Cognition
      • Manual dexterity rule out toileting skills
      • mobility
  58. Pelvic examination in women to assess:
      • Carcinoma
      • Genital atrophy
      • Paravaginal muscle tone
      • Pelvic mass
      • Perineal skin condition
      • Pelvic organ prolapse
        • Cystocele
        • Rectocele
        • Uterine prolapse
      • Urethral diverticulum
      • Urethral inflammation
    • Rectal Examination to assess:
      • Consistency and contour of prostate
      • Fecal incontinence
      • Fecal impaction
      • Perineal sensation
      • Rectal mass
      • Sphincter tone (resting and active)
    • Laboratory Testing :
      • Complete blood count (CBC)
      • Chemistry panel
      • Renal function (BUN, Creatinine)
      • Urinalysis
      • Urine culture
  59. Diagnostic Studies
    • Catherization for postvoid residual (PVR)
    • Cough stress test
    • Pelvic ultrasound
    • Urodynamic tests:
      • Cystometry to document:
        • Abnormalities of bladder compliance, Bladder capacity, Detrusor, contractions or PVR
      • Cystometrogram (CMG) to document:
        • Diversed bladder compliance
        • Increase in intraabdominal pressure
        • Involuntary detrusor contraction
  60. Diagnostic Studies: continued
    • Cystoscopy to document:
      • Sterile hematuria or pyuria
    • Cause of any of the following:
      • Bladder pain, Irritative voiding symptoms, Recurrent cystitis, Suspected foreign body
    • Electromyography (EMG) to document detrusor sphincter dyssynergia (DSD)
    • Urethral pressure profilometry (UPP) to document:
      • Intrinsic sphincter deficiency (ISD), Resting and dynamic pressures in the urethra and Sphincter function
  61. Diagnostic Studies: continued
    • Uroflometry to document urine flow rate
    • Voiding CMG to document:
      • Detrusor contractility, Outlet obstruction, Urodynamic obstruction
    • Endoscopic tests including cystourethroscopy to document:
      • Bladder lesions, Fistulas, Foreign bodies, ISD, Strictures, Urethral diverticula
    • Imaging Tests:
      • Nonvoiding lateral Cystourethrography, to document:
        • Degree of cystocele, Funneling of bladder neck and proximal urethra, Mobility or fixation of bladder neck
  62. Diagnostic Studies: continued
    • Imaging Tests:
      • Nonvoiding lateral Cystourethrography, to document:
        • Degree of cystocele, Funneling of bladder neck and proximal urethra, Mobility or fixation of bladder neck
    • Voiding Cystourethrography to document:
      • Obstruction, Urethral diverticulum, Vesicoureteral reflux
    • Upper tract imaging - excretory urography (IVP) for:
      • Incontinent patients with hematuria
      • Further evaluation of upper tract obstruction or other pathology identified by ultrasound
  63. Differential Diagnosis
    • Incontinence may be considered as fixed or transient
    • Transient incontinence usually has definable, sudden onset and often has a discrete cause
    • A simple Mneumonic summarizes the differential diagnosis of transient incontinence
  64. Etiologies for Transient Urinary Incontinence: DIAPERS Mneumonic
    • D rugs : hypnotics, sedatives, anticholinergic agents, diuretics, adrenergic agents
    • D elirium : or altered mental status
    • I nfection
    • A trophy: of vagina or urethra
    • P sychologic: functional depression
    • E ndocrine: hyperglycemia or hypercalcemia
    • R estricted mobility
    • S tool impaction
  65. Urge Incontinence
    • Strong desire to void without the ability to suppress the urinary loss
    • Results from overactivity of the detrusor resulting in uncontrollable bladder contractions
    • There is loss related to a particular activity of exposure and is the most common type of incontinence noted in elderly
    • Frequently complicates central disorders: Parkinson's, Alzheimer's, CVA and brain tumor
    • Also noted with bladder disorders: outlet obstruction, carcinoma in situ and infection
  66. Stress Incontinence
    • Urinary loss with physical activity or sudden increases in abdominal pressure
    • A deficiency of the bladder outlet
    • Result from hypermobility of urethra and bladder neck in women or from intrinsic damage in either sex
  67. Reflex Incontinence
    • Related to urge incontinence
    • Manifested by the precipitous loss of urine with no sense of urgency
    • Noted in patients with suprasacral spinal cord lesions
  68. Overflow Incontinence
    • Caused by chronic retention of urine with small volumes being frequently voided
    • May result from detrusor hypocontractility: seen in Tabes Dorsalis, diabetes mellitus or Vitamin B12 deficiency
    • May also result from bladder outlet obstruction caused by prostatic or urethral pathology with subsequent bladder decompensation
  69. Continuous Incontinence
    • Total and unabated leakage of urine unrelated to activity
    • Identified when a fistula of the urinary tract is present
    • The most common etiology for urinary tract fistula in woman is prior hysterectomy
  70. Mixed Category of Incontinence
    • More than one type of incontinence may be present
    • Especially in the elderly
    • An adult male may have both overflow incontinence due to prostatic obstruction and neurogenic bladder dysfunction secondary to diabetic neuropathy or cerebrovascular insufficiency
  71. Diagnosis & Management of Urinary Incontinence by Type
    • Retropubic suspension
    • Needle bladder neck suspension
    • Anterior vaginal repair
    • Sling procedures
    • Artificial sphincter
    • urethrolysis
    • Estrogen therapy
    • Phenylpropanolamine (hcl) (PPA)
    • Pseudo-ephedrine hcl
    • Imipramine (Tofranil-PM)
    • Provocative stress test
    • (Direct visualization)
    • Tests for bladder neck mobility
    • UPP or leak point pressure
    • Simple Multichannel CMG
    Stress Incontinence Surgical Thx Drug Thx DX studies Type of UI
  72. Diagnosis & Management of Urinary Incontinence by Type
    • Augmenta-tion intestino-cystoplasty or urinary diversion
    • Bladder denervation
    • Subtrigonal or transvesical phenol injection
    Doxazosin mesylate (Cardura) Flavoxate hcl L-Hyoscyamine (Levbid) Imipramine hcl (Tofranil-PM) Oxybutynin (Ditropan) Propantheline bromide Tamsulosin hcl (Flomax) Terazoxin hcl (Hytrin) Terodiline hcl (Micturin) Tolterodine tartrate (Detrol)
    • Simple or multi-channel CMG with or without EMG
    • Video-Urodynamic
    • Simple or multi-channel cysto-metry
    Urge incontinence Surgical Thx Drug Thx Dx Studies Type of UTI
  73. Diagnosis & Management of Urinary Incontinence by Type
    • Cutting suspending sutures from previous Endoscopic needle bladder neck suspension
    • Urethrolysis (remobilization of periurethral adhesions) with or without resuspension
    • Doxazosin mesylate (Cardura)
    • Terazoxin hcl (Hytrin)
    • Tamsulosin hydrochloride (Flomax)
    • Post void residual volume
    • Uroflowmetry
    • Voiding CMG with EMG
    • Cystourethroscopy
    • Videourodynamics
    Overflow Incontinence Surgical Thx Drug Thx DX studies Type of UI
  74. Diagnosis & Management of Urinary Incontinence by Type Urinary diversion
    • Dicyclomine hcl
    • L-Hyoscyamine (Levbid)
    • Oxybutin (Ditropan)
    • IV-urography
    • US
    • Cystography
    • Urethrography
    • Cystourethroscopy
    • Serial cystometro-gram
    • Urodynamic voiding flow Sphincter EMG
    • Urethral pressure profile studies
    Neurogenic Bladder Surgical Thx Drug Thx DX studies Type of UI
  75. Diagnosis & Management of Urinary Incontinence by Type
    • Therapy is directed toward identifying and treating the specific type of incontinence present
    • Excretory urography
    • Voiding Cystourethro-graphy
    • Retrograde urethrography
    • Cystoscopy
    • Cystometro-gram
    • Urethral pressure profile
    Mixed incontinence Drug Therapy & Surgical Thx DX studies Type of UI
  76. Diagnosis & Management of Urinary Incontinence by Type
    • Surgical excision of fistulous tract
    • Urinary diversion
    • Excretory urography
    • Voiding cystourethro-graphy
    • Vaginoscopy
    • Urethro-cystoscopy
    Urinary fistulas Artificial sphincter Residual urine Total incontinence Artificial sphincter Post-prostatectomy Incontinence Surgical Thx Drug Thx DX studies Type of UI
  77. Diagnosis & Management of Urinary Incontinence by Type psychotherapy
    • Alpha-adrenergic
    • Anticholinergic
    Diagnosis can be established only after all other causes of Urinary Incontinence are ruled out Psychogenic incontinence Surgical Thx Drug Thx DX studies Type of UI
  78. Treatment Options for Stress, Urge and Mixed Urinary Incontinence: continued
    • Neuromuscular Electrical Stimulation:
      • Electrical stimulation of the pudendal nerve causes contraction of the pelvic floor and periurethral muscles.
    • InterStim Continence Control Therapy:
      • involves electrical stimulation of the sacral nerves via a totally implantable system
  79. Patient & Family Education
    • Avoidance of cigarette smoking
    • Teaching Pelvic Muscle Exercise to symptomatic and asymptomatic younger and older women and to men who undergo prostate surgery
    • Instruct in proper lifting techniques to avoid abdominal strain
    • Encourage Frequent voiding
    • Encourage the use of protective undergarments and bedcovers
  80. Appropriate Referral and Follow-ups
    • The FNP should consider minimal invasive, nonsurgical therapies first for those with stress, urge, and mixed UI
    • These include behavioral therapies and judicious use of medications
    • Refer to specialists if further assessment is necessary or if appropriate treatments are unavailable
  81. Research
    • Study Purpose: to determine if there was a difference in pelvic floor muscle strength and reports of incontinence between women involved in high impact athletics and women who were relatively sedentary
    • The subjects were nulliparous women age 18-25 divided into 2 groups:
    • Grp I consisted of 20 women athletes who exercised a maximum of 6 hours/wk
    • Grp II: 15 women who exercised 1 hr/wk
    • Methods: Pelvic floor muscle strength was measured using EMG biofeedback via surface electrodes
    • Results: the athletic group was found to have significantly stronger pelvic floor muscle strength, p=.025.
  82. Research: continued
    • 49% of the entire sample reported incontinence with daily activities.
    • No difference was found in pelvic floor strength in subjects who reported incontinence compared to subjects with no report of incontinence.
    • Conclusions: although athletes had stronger pelvic floor muscles, they had no less report of urinary incontinence.
    • Across the entire sample, those who reported incontinence did not have significantly weaker pelvic floor muscles than those with no report of incontinence
    • This study suggested that pelvic floor strength is often not a predictor of incontinence                                                     
  83. Any Questions?

+ mona2144mona2144, 2 years ago

custom

394 views, 0 favs, 0 embeds more stats

More info about this document

© All Rights Reserved

Go to text version

  • Total Views 394
    • 394 on SlideShare
    • 0 from embeds
  • Comments 1
  • Favorites 0
  • Downloads 52
Most viewed embeds

more

All embeds

less

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

Cancel
File a copyright complaint
Having problems? Go to our helpdesk?

Categories